$GOVX
Geovax Labs Inc
PRICE
$0.5454 ▲0.981%
Extented Hours
VOLUME
155,586
DAY RANGE
0.53 - 0.5751
52 WEEK
0.5055 - 1.39
Join Discuss about GOVX with like-minded investors
@soheil.n #StockTraders.NET
$GOVX - longed both times...once it reclaimed the 10 EMA and consolidated played long for a push above the previous pivot point ...2nd long sold 3/4 into the 4.05 push and 1/3 was cut under 3.8
128 Replies 13 👍 12 🔥
@soheil.n #StockTraders.NET
looks like it's done now > @soheil.n said: $GOVX - looking to long once 4 firms up...so far putting up a fight and holding up well
50 Replies 14 👍 9 🔥
@soheil.n #StockTraders.NET
$GOVX - looking to long once 4 firms up...so far putting up a fight and holding up well
94 Replies 7 👍 14 🔥
@soheil.n #StockTraders.NET
can someone explain this print on $GOVX ..does that mean it's a seller or a buyer here:
115 Replies 15 👍 8 🔥
@soheil.n #StockTraders.NET
if 3.1 holds going for nhod > @soheil.n said: $GOVX - back side after that 3.38 clear out from last week (no borrows)
45 Replies 9 👍 12 🔥
@soheil.n #StockTraders.NET
$GOVX - back side after that 3.38 clear out from last week (no borrows)
90 Replies 13 👍 10 🔥
@BrittJ #StockTraders.NET
Hopefully you are still long $HKD.. Nice call > @Math said: $BTTX (ss) $GOVX $HKD (long)
115 Replies 9 👍 14 🔥
@singletary #StockTraders.NET
nice off highs $govx if only we could get the $siga crack to help open it up
96 Replies 10 👍 14 🔥
@soheil.n #StockTraders.NET
$GOVX - wanted it to pull back to 2.1 but that didn't happen...not chasing here...if it breaks HOD and bases at 2.24 then will look to play long for 2.4-2.5
117 Replies 13 👍 14 🔥
@soheil.n #StockTraders.NET
out all in 2.09s > @soheil.n said: $GOVX - longed some at 2.02....tight stop under 1.98
128 Replies 13 👍 12 🔥
Key Metrics
Market Cap
15.16 M
Beta
0
Avg. Volume
205.48 K
Shares Outstanding
26.44 M
Yield
0%
Public Float
0
Next Earnings Date
2023-11-08
Next Dividend Date
Company Information
geovax labs, inc., (otcqb: govx) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our modified vaccinia ankara - virus-like particle (mva-vlp) vaccine platform. our development programs are focused on preventive vaccines against hiv, zika virus, hemorrhagic fever viruses (ebola, sudan, marburg, and lassa), and malaria, as well as therapeutic vaccines for chronic hepatitis b infections and cancers. our mva-vlp platform supports in vivo production of non-infectious vlps from the cells of the very person receiving the vaccine, mimicking a natural infection, and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. for more information, visit www.geovax.com.
CEO: David Dodd
Website: https://www.geovax.com/
HQ: 11465 Johns Creek Pkwy Ste 400 Smyrna, 30080 Georgia
Related News